By Cara Murez 

HealthDay Reporter

FRIDAY, March 31, 2023 (HealthDay Information) — Cats always licking and chewing due to a pores and skin situation known as feline allergic dermatitis might profit from a brand new generic remedy accepted by the U.S. Meals and Drug Administration.

The FDA accepted Modulis for Cats on March 29, making it the primary generic cyclosporine oral answer for cats with pores and skin circumstances ensuing from this allergic dermatitis.

The immunosuppressant drug tamps down the allergic course of that causes cats with this situation to be itchy.

The treatment incorporates the identical focus and dosage of cyclosporine as an accepted brand-name drug, Atopica for Cats. That treatment was accepted in August 2011.

Cats with this situation might be intensely itchy. They might lick, chew and scratch at their pores and skin and hair.

This may trigger them to develop different pores and skin points, together with miliary dermatitis, lesions often called eosinophilic plaques and hair loss.

Cats should be at the very least 6 months previous and weigh 3 kilos to make use of the treatment, which is barely obtainable from a veterinarian.

Individuals who administer this to their cat ought to keep away from by chance ingesting the drug. Don’t eat, drink, smoke or use smokeless tobacco whereas dealing with it, the FDA suggested.

Wash your arms after giving Modulis for Cats to your pet. Folks with identified hypersensitivity to cyclosporine ought to keep away from contact with the product, the FDA warned.

The treatment is sponsored by Provetica, LLC, based mostly in Lenexa, Kan. It is available in three sizes.

Extra info

The American Affiliation of Feline Practitioners has extra on feline allergic dermatitis.


SOURCE: U.S. Meals and Drug Administration, information launch, March 29, 2023

Supply hyperlink